Search Clinical Trials ?


Protocols

Trials Open: 11
Cancer Type: Gastrointestinal Cancer
Protocol No.Title
15-GI-95-NLGIndoximod + Gemcitabine and Nab-Paclitaxel for Metastatic Pancreatic Cancer
16-MULTI-15-SIRovalpituzumab Tesirine for DLL3 Expressing Advanced Solid Tumors
MCC-13-MULTI-13-KCTN-1301Optimization of Smoking Cessation Strategies Concurrent w/Treatment of Tobacco Related Malignancies
MCC-14-MULTI-14Effects of Hydroxychloroquine on PAR-4 Levels for Resectable Solid Tumors
MCC-16-GI-98TVB 2640 for Resectable Colon Cancer
MCC-16-GI-99Fosbretabulin with Everolimus in Neuroendocrine tumors with progression
MCC-16-HN-29Cisplatin + radiation in SCCHN and Correlation with Oxidative Stress Markers
MCC-16-MULTI-18Genomic Testing for Patients with Refractory Cancer to Determine Treatment
MCC-16-MULTI-19Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
NCI-CIRB-APEC14B1Project:EveryChild
NCI-CIRB-S0820NCI-CIRB-S0820 A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Ademnomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES)